Dellann Elliott Mydland on Testing Brain Tumor Tissue

Article

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.

Dellann Elliott Mydland, from the Chris Elliott Fund, discusses the importance of testing brain tumor tissue before surgery.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
4 experts in this video
4 experts in this video
4 experts in this video
4 experts in this video
Image of a woman with light brown hair wearing glasses with a blue background
Image of a woman wearing glasses in front of a blue background
Image of a woman with glasses in front of a blue background
Image of a man in a suit smiling in front of an Oncology Nursing News background
Related Content
Photo of a woman with brown hair and bangs, surrounded by a blue border

AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

Michelle Kirschner, RN, MSN, ACNP, APRN-BC
June 30th 2025
Article

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, APRN-BC.

The Vitals

Jacki Garcia and Kristin Hendrickson on Navigating Patients Through Phase 0 Trials

Lindsay Fischer
July 15th 2023
Podcast

Jacki Garcia, RN, BSN, CNRN; and Kristin Hendrickson, BA, RN, discuss phase 0 trials and how they can help expedite the research process for brain cancer therapies.

Illustration of a brain with a magnifying glass showing a tumor. Behind the brain is a medical chart.

NCCN Guidelines Now Recommend Naxitamab for High-Risk Neuroblastoma

Jax DiEugenio
May 9th 2025
Article

An update to the NCCN guidelines recommends naxitamab-gqgk for adult and pediatric patients with high-risk neuroblastoma.

Image of a pediatric patient with a headwrap with an upset face holding a teddy bear

Racial, Ethnic Disparities Present in Pediatric Brain Cancer Survival

Russ Conroy
May 8th 2025
Article

Black and Hispanic pediatric patients with high-risk neuroblastoma had significantly lower 5-year survival rates in induction and/or consolidation trials.

Line illustration of a person with lines emphasizing the brain

TLX101-CDx Given Complete Response Letter for Glioma Imaging

Chris Ryan
May 6th 2025
Article

The FDA granted a complete response letter with no safety concerns for the new drug application for TLX101-CDx’s use in glioma imaging.

Graphic image of a blue brain on a blue background

Breakthrough Designation Granted to BCB-276 for Pediatric DIPG

Chris Ryan
April 25th 2025
Article

Findings from the phase 1 BrainChild-03 trial support breakthrough designation for BCB-276 for pediatric diffuse intrinsic pontine glioma.